WallStreetZenWallStreetZen

NASDAQ: PSTV
Plus Therapeutics Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their PSTV stock forecasts and price targets.

Forecast return on equity

Is PSTV forecast to generate an efficient return?

Forecast return on assets

Is PSTV forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

PSTV revenue forecast

What is PSTV's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$9.4M+91.94%
Avg 2 year Forecast
$7.8M+59.58%
Avg 3 year Forecast
$7.9M+59.78%
PSTV's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PSTV revenue growth forecast

How is PSTV forecast to perform vs Biotechnology companies and vs the US market?
Company
13.89%
Industry
39.22%
Market
10.52%
PSTV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PSTV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PSTV vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PSTV$1.81N/AN/A
PTIX$1.75N/AN/A
ADXN$12.80N/AN/A
GRTX$0.14N/AN/A
PYPD$4.60$13.00+182.61%Buy

Plus Therapeutics Stock Forecast FAQ

What is PSTV's revenue growth forecast for 2024-2027?

(NASDAQ: PSTV) Plus Therapeutics's forecast annual revenue growth rate of 13.89% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 39.22%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Plus Therapeutics's revenue in 2024 is $4,913,000.On average, 1 Wall Street analysts forecast PSTV's revenue for 2024 to be $40,323,453, with the lowest PSTV revenue forecast at $40,323,453, and the highest PSTV revenue forecast at $40,323,453. On average, 1 Wall Street analysts forecast PSTV's revenue for 2025 to be $33,524,483, with the lowest PSTV revenue forecast at $33,524,483, and the highest PSTV revenue forecast at $33,524,483.

In 2027, PSTV is forecast to generate $33,567,244 in revenue, with the lowest revenue forecast at $33,567,244 and the highest revenue forecast at $33,567,244.

If you're new to stock investing, here's how to buy Plus Therapeutics stock.

What is PSTV's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: PSTV) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is PSTV's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: PSTV) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.